Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases. The company's product candidates include NGN-401 that is packaged in an adeno-associated virus 9, which is in Phase 1/2 clini...
Leadership
Rachel L. McMinn Ph.D.Founder
Founder, Executive Chair & CEO
Christine Mikail Cvijic J.D.
President, CFO & Director
Julie Jordan M.D.
Chief Medical Officer
Stuart Cobb Ph.D.
Chief Scientific Officer
Donna M. Cochener-Metcalfe J.D., L.L.M.
Senior VP, General Counsel & Corporate Secretary
Andrew E. Mulberg CPI, FAAP, M.D.
Senior VP of Regulatory Affairs, Quality Assurance & Quality Control
